Firms
Altitude Life Science Ventures
- Founded
- —
- Type
- Venture capital
Team
No team members on record yet.
Co-investing
ARCH Venture Partners
Vilya$71M · 2024-06-04
Vilya Therapeutics$71M · 2024-06-04
Generate Biomedicines Inc$370M · 2021-11-18
Mozart Therapeutics$55M · 2021-10-26
Omniome$60M · 2020-01-09
Sienna Biopharmaceuticals$40M · 2017-04-27
Sienna Biopharmaceuticals$40M · 2017Kythera Biopharmaceuticals$37M · 2011-09-19
BlackThorn Therapeutics$14M · Unknown date
Neumora Therapeutics$112M · Unknown date
Fidelity Management & Research Company
Generate Biomedicines Inc$370M · 2021-11-18
Sienna Biopharmaceuticals$40M · 2017-04-27
Lifeforce Capital
Vilya$71M · 2024-06-04
Vilya Therapeutics$71M · 2024-06-04
Madrona Venture Group
Vilya$71M · 2024-06-04
Vilya Therapeutics$71M · 2024-06-04
Menlo Ventures
Vilya$71M · 2024-06-04
Vilya Therapeutics$71M · 2024-06-04
Abu Dhabi Investment Authority
Generate Biomedicines Inc$370M · 2021-11-18
Alaska Permanent Fund
Generate Biomedicines Inc$370M · 2021-11-18
Alexandria Venture Investments
Mozart Therapeutics$55M · 2021-10-26
Biomatics Capital
BlackThorn Therapeutics$14M · Unknown date
Decent Capital
Omniome$60M · 2020-01-09
Domain Associates
Omniome$60M · 2020-01-09
Exor Ventures
Neumora Therapeutics$112M · Unknown date
F-Prime Capital
Neumora Therapeutics$112M · Unknown date
Flagship Pioneering
Generate Biomedicines Inc$370M · 2021-11-18
GV
BlackThorn Therapeutics$14M · Unknown date
JAFCO Group Co., Ltd.
Kythera Biopharmaceuticals$37M · 2011-09-19
Leaps by Bayer
Mozart Therapeutics$55M · 2021-10-26
Mangrove Capital Partners
Omniome$60M · 2020-01-09
Mercury Fund
BlackThorn Therapeutics$14M · Unknown date
Morningside Ventures
Generate Biomedicines Inc$370M · 2021-11-18
MRL Ventures Fund
Mozart Therapeutics$55M · 2021-10-26
Mubadala Ventures
Neumora Therapeutics$112M · Unknown date
NVentures
Vilya Therapeutics$71M · 2024-06-04
Pivotal Life Sciences
Omniome$60M · 2020-01-09
Premier Partners
Neumora Therapeutics$112M · Unknown date
Sofinnova Partners
Mozart Therapeutics$55M · 2021-10-26
T. Rowe Price Associates
Generate Biomedicines Inc$370M · 2021-11-18
Versant Ventures
Kythera Biopharmaceuticals$37M · 2011-09-19